The invention describes a
yeast for the
dietary therapy of diabetes and a construction method thereof. A
saccharomyces cerevisiae
genome DNA as a template is used for amplifying two sections of rDNA sequences; pYX212 as a template is used for amplifying a nutritional
marker gene URA3 and an
expression cassette segment driven by a triosephosphate
isomerase promoter; the four amplified products are respectively cloned at corresponding loci of pUC18, and thereby an integrating vector pNK1 is obtained.
A DNA synthesization
point mutation technique is then utilized to remove the restriction sites of dipeptidase VI and
trypsin in the natural GLP-1 molecule, so that type I primer segments, type II primer segments and left and right connected filling primer segments are synthesized, and a ten-repeat tandem rolGLP-1 sequence is obtained by the method of step-by-step annealing and one-step connection, and is cloned in the pNK1, so that pNK-GLP is obtained. The pNK-GLP is then linearized,
saccharomyces cerevisiae BJ2407 is transformed, and after screening,
recombinant yeast SG2 is obtained. Because the rolGLP-1
gene is integrated in
yeast chromosome, the recombinant strain can stably and efficiently express the characteristics of the rolGLP-1 and reduce the
blood sugar level of a rat with hyperglycaemia, and can be used in the development of
yeast biomedicine for treating diabetes.